RxDoctor Payments Data

Michelle Gooch

Acute Care · Chattanooga, TNNPI 1528123114

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (46.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by United Therapeutics Corporation at 34.1% of the total. Among acute care clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$34,882in general payments, 2019–2025

Across 397 payments — averaging $87.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • United Therapeutics Corporation$12K
  • Takeda Pharmaceuticals U.S.A., Inc.$8K
  • Grifols USA, LLC$7K
  • AstraZeneca$2K
  • Actelion Pharmaceuticals US, Inc.$2K
  • GSK$824
  • plus $3K from 23 others

What the payments were for

  • Consulting fees$4,20612%
  • Speaking & faculty fees$16,27447%
  • Travel & lodging$5,67116%
  • Food & beverage$8,50424%
  • Education$2281%

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$34,882 in reported general payments places this provider in the 95th percentile of 738 acute care providers in Tennessee.

See all acute care providers in Tennessee

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$12,929
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$9,812
Albuterol Sulfate HfaAlbuterol Sulfate16$529
Azithromycin24$284
Montelukast Sodium15$202

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$824$12,92912 claims
AstraZenecaBreztri Aerosphere$2,466$9,81214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 738 acute care providers in Tennessee.

Other acute care in Chattanooga

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →